placebo, fostamatinib

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Rheumatoid Arthritis

Phase 3

Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.

CompletedNCT01197534

AstraZenecaRheumatoid Arthritis

Start: 2010-09-30End: 2013-03-31Updated: 2014-04-17

Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.

CompletedNCT01197521

AstraZenecaRheumatoid Arthritis

Start: 2010-09-30End: 2012-11-30Updated: 2014-04-07

Related Papers

Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis

RMD Open2022-12-013 citations